Abstract
Fusarium spp. are environmental hyaline molds that are pathogens in plants and opportunistic pathogens in humans. In immunocompetent individuals, Fusarium sp. infections primarily include keratitis, onychomycosis, and localized infections due to trauma. However, in immunocompromised patients, particularly those with hematological malignancies, members of this genus can cause devastating, invasive, and disseminated infections with high mortality. In general, these species are resistant to therapy with a variety of antifungal agents. This article reviews recent literature about human infections caused by Fusarium spp., treatment and outcomes, and methods for accurately identifying isolates recovered from clinical specimens.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
